Hence, we believe that RECQ1 would be an ideal target for chemotherapy especially in the case of brain tumors since its depletion by RNAi, or its inhibition by selective compounds, would primarily affect tumoral cells. This evidence concerns the gene RECQL and brain neoplasm.